Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy

International Journal of Clinical Oncology

Volumn 18, Issue 1, 2013, Pages 54-61

  Nagao, Tomoya ^a   Kinoshita, Takayuki ^a   Tamura, Nobuko ^a   Hojo, Takashi ^a   Morota, Madoka ^a   Kagami, Yoshikazu ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast cancer; Locoregional recurrence; Outcome; Postmastectomy radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; PACLITAXEL; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; POSTMASTECTOMY RADIOTHERAPY; POSTMENOPAUSE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84874109339     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0343-y     Document Type: Article

References (23)

1. Overgaad M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949-955
2. Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962
3. Olson JE, Neuberg D, Pandya KJ et al (1997) The role of radiotherapy in the management of operative locally advanced breast cancer: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 79:1138-1149
4. Pierce LJ (2006) The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 23:1706-1717
5. Katz A, Strom EA, Buchholz TA et al (2001) The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 50:733-742
6. Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247-253
7. Truong PT, Olivotto IA, Whelan TJ et al (2004) Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170:1263-1273
8. Marks LB, Zeng J, Prosnitz LR (2008) One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol 28:2075-2077
9. Goldhirsch A, Glick JH, Gelber RD et al (1998) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601-1608
10. Goldhirsch A, Glick JH, Gelber RD et al (2001) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19:3817-3827
11. Goldhirsch A, Wood WC, Gelber RD et al (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:3357-3365
12. Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569-1583
13. Goldhirsch A, Wood WC, Gelber RD et al (2007) Progress and promise: highlights of international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133-1144
14. The World Health Organization (1983) The World Health Organization histological typing of breast tumors second edition. Am J Clin Pathol 78:806-816
15. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histopathological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403-410
16. The Japanese Breast Cancer Society (2008) General rules for clinical and pathological recording of breast cancer, 16th edn. Kanehara, Tokyo (in Japanese)
17. Tsuda H, Akiyama F, Kurosumi M et al (1998) Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Jpn J Clin Oncol 28:486-491
18. Katz A, Strom EA, Buchholz TA et al (2000) Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implication for postoperative irradiation. J Clin Oncol 18:2817-2827
19. Wallgren A, Bonetti RD, Gelber RD et al (2003) Risk factors for locoregional recurrence among breast cancer patients: results from international breast cancer study group trials I through VII. J Clin Oncol 21:1205-1213
20. Nielsen HM, Overgaard M, Grau C et al (2006) Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol 79:147-155
21. Yildirum E (2009) Locoregional recurrence in breast carcinoma patients. Eur J Surg Oncol 35:258-265
22. Taghian A, Jeong JH, Mamounas E et al (2004) Patterns of locoregional failure in patients with operative breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol 22:4247-4254
23. Kyndi M, Sørensen FB, Knudsen H et al (2009) Response to postmastectomy radiotherapy in high-risk breast cancer: the Danish breast cancer cooperate group. J Clin Oncol 26:1419-1426